JWM
RMD icon

Janiczek Wealth Management’s ResMed RMD Stock Holding History

Janiczek Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$85.6K Sell
447
-42
-9% -$8.52K 0.02% 310
2024
Q1 		$96.8K Sell
489
-1
-0.2% -$183 0.02% 293
2023
Q4 		$84.3K Buy
490
+404
+470% +$62.1K 0.02% 298
2023
Q3 		$12.7K Sell
86
-343
-80% -$62K ﹤0.01% 594
2023
Q2 		$93.7K Sell
429
-6
-1% -$1.34K 0.03% 230
2023
Q1 		$97.7K Sell
435
-50
-10% -$10.8K 0.03% 219
2022
Q4 		$104K Sell
485
-53
-10% -$11.6K 0.03% 215
2022
Q3 		$118K Sell
538
-9
-2% -$2.05K 0.04% 172
2022
Q2 		$132K Buy
547
+239
+78% +$50.9K 0.04% 162
2022
Q1 		$75K Buy
308
+79
+34% +$19.1K 0.02% 250
2021
Q4 		$60K Buy
229
+35
+18% +$9.08K 0.02% 277
2021
Q3 		$51K Buy
194
+48
+33% +$13.1K 0.02% 282
2021
Q2 		$36K Sell
146
-28
-16% -$5.89K 0.01% 315
2021
Q1 		$34K Sell
174
-8
-4% -$1.6K 0.01% 304
2020
Q4 		$39K Buy
182
+148
+435% +$29.5K 0.02% 242
2020
Q3 		$6K Buy
+34
New +$6.28K ﹤0.01% 320

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janiczek Wealth Management's RMD Position: Q2 2024 in Review

Janiczek Wealth Management reduced its ResMed (RMD) stake by 8.6% in Q2 2024, selling an estimated $8.52K and leaving 447 shares worth $85.6K. The position accounts for 0.02% of the portfolio, ranked #310.

Janiczek Wealth Management first reported a position in RMD in Q3 2020 and has held it in 16 quarters since. The position peaked at $132K in Q2 2022. 771 funds tracked by Wall St. Rank hold RMD as of Q2 2024.

  • Janiczek Wealth Management held 447 shares of ResMed worth $85.6K as of Q2 2024.
  • Janiczek Wealth Management sold 42 ResMed shares in Q2 2024, an estimated $8.52K.
  • ResMed made up 0.02% of Janiczek Wealth Management's portfolio in Q2 2024, its #310 holding.
  • Janiczek Wealth Management first reported a position in ResMed in Q3 2020 and has held it in 16 quarters since.
  • Janiczek Wealth Management's ResMed position peaked at $132K in Q2 2022.
  • 771 funds tracked by Wall St. Rank held ResMed as of Q2 2024.

Based on Janiczek Wealth Management's 13F filing for Q2 2024, filed 25 Jul 2024.